diaziquone has been researched along with Brain Neoplasms in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (71.79) | 18.7374 |
1990's | 10 (25.64) | 18.2507 |
2000's | 1 (2.56) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Driscoll, JS; Khan, AH | 1 |
Bedikian, AY; Benjamin, RS; Burgess, MA; Feun, LG; Fields, WS; Leavens, ME; Obbens, EA; Savaraj, N; Stewart, DJ; Yung, WK | 1 |
Bjornsson, TD; Falletta, JM; Friedman, HS; Schold, SC | 1 |
Collins, JM; Curt, GA; Kelley, JA; Kornblith, PL; Kufta, CV; Smith, BH; Young, RC | 1 |
Benjamin, RS; Burgess, MA; Feun, LG; Leavens, ME; Loo, TL; Lu, K; Savaraj, N; Stewart, D | 1 |
Bachur, NR; Bellis, EH; Collins, JM; Egorin, MJ; Salcman, M; Spiegel, JF | 1 |
Bigner, DD; Bjornsson, TD; Friedman, HS; Schold, SC | 1 |
Avellanosa, A; Bhimani, S; DeLos Santos, R; Kirshner, J; Madajewicz, S; Perry, A; Spaulding, M; Zeigler, P | 1 |
Feola, J; Houchens, DP; Ovejera, AA; Slagel, DE | 1 |
Kimler, BF | 1 |
Burger, PC; Byar, DP; Green, SB; Mahaley, MS; Malkin, MG; Pistenmaa, DA; Ransohoff, J; Shapiro, WR; Strike, TA; Vogel, FS | 1 |
Archibald, YM; Barr, HW; Cairncross, JG; Del Maestro, RF; Fisher, BJ; Gaspar, LE; Lunn, D; Macdonald, DR; Pexman, JH; Ruttan, LA | 1 |
Dowling, S; Gaspar, L; Halperin, EC; Herndon, J; Imperato, J; Salter, M | 1 |
Bigner, DD; Burger, PC; Cairncross, JG; Dropcho, EJ; Halperin, EC; Herndon, JE; Macdonald, DR; Morawetz, R; Schold, SC; Vick, NA | 1 |
Evans, RG; Kimler, BF; Liu, C; Morantz, RA | 2 |
George, SL; Peterson, BL; Potthoff, RF | 1 |
Burger, P; Castleberry, RP; Kamen, B; Krischer, JP; Norris, D; Ragab, AH; Starling, K; Steuber, CP; Toledano, S | 1 |
Ettinger, LJ; Hammond, GD; Krailo, M; Krivit, W; Ru, N; Ruccione, KS | 1 |
Bell, B; Castleberry, R; Cushing, B; Falletta, JM; Krance, RA; Lauer, S; Mahoney, DH | 1 |
Carrasco, CH; Charnsangavej, C; Feun, LG; Gianturco, C; Lee, YY; Savaraj, N; Wallace, S; Yung, WK | 1 |
Coleman, RE; Djang, WT; Falletta, JM; Friedman, HS; Halperin, EC; Kurtzberg, J; Longee, DC; Oakes, WJ; Schold, SC | 1 |
Bruner, JM; Feun, LG; Harris, MI; Yung, WK | 1 |
Ali-Osman, F; Dougherty, D; Giblin, J; Rosenblum, ML | 1 |
Al Sarraf, M; Austin, D; Decker, DA; Kresge, C; Wilner, HI | 1 |
Bender, JF; Chaffee, B; Ensminger, WD; Gebarski, S; Greenberg, HS; Grillo-Lopez, AJ; Layton, PB; Meyer, M | 1 |
D'Incalci, M; Day, R; Erickson, LC; Kohn, KW; Kornblith, PL; Laurent, G; Sariban, E; Smith, BH; Zlotogorski, C | 1 |
Ettinger, LJ; Hammond, GD; Krailo, M; Krivit, W; Ruccione, KS | 1 |
Chamberlain, MC; Levin, VA; Prados, MD; Silver, P | 1 |
Cairncross, JG; Macdonald, DR | 1 |
Cascino, TL; Dinapoli, RP; Eagan, RT; O'Fallon, JR; O'Neill, BP; Scheithauer, B | 1 |
Allen, JC; Bloom, J; Ertel, I; Evans, A; Hammond, D; Jenkin, D; Jones, H; Levin, V; Sposto, R; Wara, W | 1 |
Bona, JD; Edwards, JA; Hawkins, C; Hirschfeld, A; Kornblith, PL; Matuzic, N; Rosa, L | 1 |
Erexson, GL; Kligerman, AD; Schold, SC; Wilmer, JL | 1 |
Abeloff, MD; Camacho, FJ; Chang, AY; Creech, RH; Ettinger, DS; Finkelstein, DM | 1 |
Calliauw, L; Roels, H; Sieben, G; van Oostveldt, P | 1 |
Grillo-Lopez, AJ; Jacquillat, C; Maral, J; Mashaly, P; Pertuiset, BF; Poisson, M; Weil, M | 1 |
Bjornsson, TD; Falletta, JM; Friedman, HS; Schneider, D; Schold, SC | 1 |
2 review(s) available for diaziquone and Brain Neoplasms
Article | Year |
---|---|
New drugs and new delivery techniques.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carboplatin; Carmustine; Cisplatin; Etoposide; Humans; Infusions, Intra-Arterial; Interferons; Nitrosourea Compounds; Organoplatinum Compounds; Rats | 1985 |
Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Glioma; Humans; Medulloblastoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrosourea Compounds | 1986 |
7 trial(s) available for diaziquone and Brain Neoplasms
Article | Year |
---|---|
Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Humans; Middle Aged; Nitrosourea Compounds; Prospective Studies; Recurrence; Survival Analysis | 1994 |
An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Oligodendroglioma; Radiography; Radiotherapy Dosage; Survival Analysis | 1993 |
Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
Topics: Adult; Analysis of Variance; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Combined Modality Therapy; Female; Glioma; Humans; Male; Middle Aged; Proportional Hazards Models; Survival Analysis | 1993 |
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Drugs, Investigational; Humans; Neoplasm Recurrence, Local; Neoplasms | 1990 |
Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Glioma; Humans; Medulloblastoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrosourea Compounds | 1986 |
Sister chromatid exchange induction in patients with anaplastic gliomas undergoing treatment with radiation plus diaziquone or 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Carmustine; Combined Modality Therapy; Female; Glioma; Humans; Lymphocytes; Male; Radiation, Ionizing; Sister Chromatid Exchange; Time Factors | 1987 |
Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
Topics: Aclarubicin; Adult; Aged; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Random Allocation | 1985 |
31 other study(ies) available for diaziquone and Brain Neoplasms
Article | Year |
---|---|
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
Topics: Animals; Antineoplastic Agents; Aziridines; Brain Neoplasms; Central Nervous System; Ependymoma; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Quinones | 1976 |
A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Drug Evaluation; Glioblastoma; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local | 1984 |
Treatment of patients with recurrent primary brain tumors with AZQ.
Topics: Adolescent; Adult; Aged; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Ependymoma; Female; Glioma; Humans; Male; Medulloblastoma; Middle Aged | 1984 |
Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Blood-Brain Barrier; Brain Neoplasms; Drug Evaluation; Female; Glioma; Humans; Kinetics; Male; Middle Aged | 1983 |
Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986).
Topics: Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain; Brain Neoplasms; Humans; Middle Aged; Tissue Distribution | 1983 |
The pharmacology of diaziquone given in intravenous or intracarotid infusion to normal and intracranial tumor-bearing puppies.
Topics: Animals; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Carotid Arteries; Dogs; Glioma; Infusions, Parenteral; Kinetics | 1984 |
Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cell Division; Cell Line; Drug Evaluation, Preclinical; Glioma; Humans; Medulloblastoma; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1984 |
Phase I-II diaziquone chemotherapy in brain tumors.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged | 1984 |
Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Topics: Animals; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Cell Line; Glioma; Humans; Medulloblastoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Procarbazine; Time Factors; Transplantation, Heterologous | 1982 |
The 9L rat brain tumor model for pre-clinical investigation of radiation-chemotherapy interactions.
Topics: Animals; Antineoplastic Agents; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Radiation; Gliosarcoma; Male; Organometallic Compounds; Rats; Rats, Inbred F344; Spiro Compounds; Vincristine | 1994 |
Cognitive functioning in long-term survivors of high-grade glioma.
Topics: Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Cognition; Female; Glioma; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects | 1994 |
Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Cesium Radioisotopes; Cisplatin; Combined Modality Therapy; Disease Models, Animal; Humans; Male; Rats; Rats, Inbred F344; Survival Rate | 1993 |
Detecting treatment-by-centre interaction in multi-centre clinical trials.
Topics: Aged; Antineoplastic Agents, Alkylating; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Computer Simulation; Glioma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Remission Induction; Statistics as Topic | 2001 |
Intracerebral chemotherapy in the 9L rat brain tumor model.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Injections, Intralesional; Injections, Intraperitoneal; Isoxazoles; Male; Neoplasm Transplantation; Rats; Rats, Inbred F344 | 1992 |
A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male | 1990 |
Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Cohort Studies; Drug Therapy, Combination; Glioma; Humans; Lomustine; Male; Neoplasm Recurrence, Local; Procarbazine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Intravenous BCNU and AZQ in patients with recurrent malignant gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Female; Glioma; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local | 1989 |
Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Biological Assay; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Ellipticines; Glioma; Half-Life; Humans; Mathematics; Streptozocin; Teniposide | 1987 |
Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma | 1985 |
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow; Brain Neoplasms; Carmustine; Drug Evaluation; Eye; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local | 1986 |
DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone.
Topics: Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Cells, Cultured; Cisplatin; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Drug Resistance; Ethylnitrosourea; Glioblastoma; Humans; Neoplasm Proteins; Nitrosourea Compounds | 1987 |
A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Leukemia; Male | 1988 |
A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Drug Evaluation; Humans; Infusions, Intravenous; Neoplasm Recurrence, Local | 1988 |
Successful chemotherapy for recurrent malignant oligodendroglioma.
Topics: Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Female; Humans; Lomustine; Male; Middle Aged; Oligodendroglioma; Procarbazine; Vincristine | 1988 |
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
Topics: Adolescent; Adult; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia | 1987 |
Response variability of human brain tumors to AZQ in tissue culture.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cell Line; Culture Techniques; Dose-Response Relationship, Drug; Glioma; Humans | 1986 |
The influence of AZQ on the DNA distribution of human cerebral tumours in short-term culture.
Topics: Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cell Cycle; Culture Techniques; DNA, Neoplasm; Humans; Ploidies | 1985 |
Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Drug Evaluation; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1985 |
Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Blood-Brain Barrier; Brain Neoplasms; Combined Modality Therapy; Drug Evaluation; Female; Glioma; Humans; Male; Middle Aged | 1985 |
Pharmacokinetics of diaziquone after three different dosage regimens.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Chromatography, High Pressure Liquid; Half-Life; Humans; Infusions, Parenteral; Kinetics; Metabolic Clearance Rate | 1985 |